P. Sow, L. Otieno, E. Bissagnene, C. Kityo, R. Bennink et al., Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.44, issue.3
DOI : 10.1097/QAI.0b013e31802bf109

S. Toure, B. Kouadio, C. Seyler, M. Traore, N. Dakoury-dogbo et al., Rapid scaling-up of antiretroviral therapy in 10 000 adults in C??te d??Ivoire: 2-year outcomes and determinants, AIDS, vol.22, issue.7, pp.873-82, 2008.
DOI : 10.1097/QAD.0b013e3282f768f8

D. Ekouevi, E. Balestre, F. Ba-gomis, S. Eholie, M. Maiga et al., Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa, Tropical Medicine & International Health, vol.85, pp.34-42, 2010.
DOI : 10.1111/j.1365-3156.2010.02505.x

I. Wilson and P. Cleary, Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes, JAMA: The Journal of the American Medical Association, vol.273, issue.1, pp.59-65, 1995.
DOI : 10.1001/jama.273.1.59

D. Revicki, S. Sorensen, and A. Wu, Reliability and Validity of Physical and Mental Health Summary Scores from the Medical Outcomes Study HIV Health Survey, Medical Care, vol.36, issue.2, pp.126-163, 1998.
DOI : 10.1097/00005650-199802000-00003

J. Ware, J. Kosinski, M. Gandek, B. Aaronson, N. Apolone et al., The Factor Structure of the SF-36 Health Survey in 10 Countries, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1159-65, 1998.
DOI : 10.1016/S0895-4356(98)00107-3

A. Wu, K. Hanson, G. Harding, S. Haider, M. Tawadrous et al., Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies, Health and Quality of Life Outcomes, vol.11, issue.1, p.42, 2013.
DOI : 10.1097/00002030-200109280-00010

D. Clayson, D. Wild, P. Quarterman, I. Duprat-lomon, M. Kubin et al., A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials, PharmacoEconomics, vol.1, issue.11, pp.751-65, 2006.
DOI : 10.2165/00019053-200624080-00003

J. Jelsma, E. Maclean, J. Hughes, X. Tinise, and M. Darder, An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART, AIDS Care, vol.273, issue.5, pp.579-88, 2005.
DOI : 10.1097/00002030-200007070-00019

A. Stangl, N. Wamai, J. Mermin, A. Awor, and R. Bunnell, Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda, AIDS Care, vol.7, issue.5, pp.626-662, 2007.
DOI : 10.1023/A:1018451930750

J. Pitt, L. Myer, R. Wood, C. Heunis, D. Van-rensburg et al., Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling103. 13. UNAIDS. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011 Available from: http://www.who.int/hiv/pub/progress_ report2011/en/index.html 14 Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption?II The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation, HIV-infected patients on antiretroviral therapy in West African countries, pp.1013-1036, 1993.

M. Preau, F. Marcellin, M. Carrieri, F. Lert, Y. Obadia et al., Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study, AIDS, vol.21, issue.Suppl 1, pp.19-27, 2007.
DOI : 10.1097/01.aids.0000255081.24105.d7

P. Carrieri, B. Spire, S. Duran, C. Katlama, D. Peyramond et al., Health-related quality of life after 1 year of highly active antiretroviral therapy):38Á47. 19. O'Keefe EA, Wood R. The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population, J Acquir Immune Defic Syndr. Qual Life Res, vol.325, issue.12, pp.275-80, 1996.

J. Ware, J. Gandek, B. Kosinski, M. Aaronson, N. Apolone et al., The Equivalence of SF-36 Summary Health Scores Estimated Using Standard and Country-Specific Algorithms in 10 Countries, Journal of Clinical Epidemiology, vol.51, issue.11, pp.1167-70, 1998.
DOI : 10.1016/S0895-4356(98)00108-5

A. Justice, W. Holmes, A. Gifford, L. Rabeneck, R. Zackin et al., Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001.
DOI : 10.1016/S0895-4356(01)00449-8

S. Duran, B. Spire, F. Raffi, V. Walter, D. Bouhour et al., Selfreported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, HIV Clin Trials. Soc Sci Med, vol.254, issue.110, pp.1481-96, 2001.

A. Jaquet, http://www.jiasociety.org/index, Journal of the International AIDS Society, vol.16, p.18867, 2013.

A. Fontaine, F. Larue, and J. Lassauniere, Physicians' Recognition of the Symptoms Experienced by HIV Patients, Journal of Pain and Symptom Management, vol.18, issue.4, pp.263-70, 1999.
DOI : 10.1016/S0885-3924(99)00078-0

J. Mrus, P. Williams, J. Tsevat, S. Cohn, and A. Wu, Gender differences in health-related quality of life in patients with HIV/AIDS, Quality of Life Research, vol.339, issue.2, pp.479-91, 2005.
DOI : 10.1007/s11136-004-4693-z

A. Jaquet, M. Djima, P. Coffie, H. Kacou, S. Eholie et al., Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire, Pharmacoepidemiology and Drug Safety, vol.40, issue.1, pp.1303-1313, 2011.
DOI : 10.1002/pds.2182

P. Braitstein, P. Ayuo, A. Mwangi, K. Wools-kaloustian, B. Musick et al., Sustainability of First-Line Antiretroviral Regimens: Findings From a Large HIV Treatment Program in Western Kenya, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, issue.2, pp.254-263, 2010.
DOI : 10.1097/QAI.0b013e3181b8f26e

S. Mannheimer, N. Wold, E. Gardner, E. Telzak, H. Hullsiek et al., Australians with HIV infection Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria Healthcare providers' experiences with adverse drug reactions and adherence challenges in antiretroviral therapy of HIV patients in the Eastern Cape Province, South Africa, ):941Á5. 32, pp.56-31141321, 2008.

H. Jia, C. Uphold, S. Wu, G. Chen, P. Duncan et al., Predictors of changes in health-related quality of life among men with HIV infection in the HAART era Free care at the point of service delivery: a key component for reaching universal access to HIV/ AIDS treatment in developing countries, ):395Á405. 35. Souteyrand YP, pp.161-169, 2005.

V. Ridde, P. Some, and C. Pirkle, NGO-provided free HIV treatment and services in Burkina Faso: scarcity, therapeutic rationality and unfair process, International Journal for Equity in Health, vol.11, issue.1, p.11, 2012.
DOI : 10.1503/cmaj.109-3149

A. Jaquet, http://www.jiasociety.org/index, Journal of the International AIDS Society, vol.16, p.18867, 2013.